Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03323150

Ligand	Ligand name	Chain	PDB	Tanimoto
CND	5-BETA-D-RIBOFURANOSYLNICOTINAMIDE ADENINE DINUCLEOTIDE	A,B	1ADB	0.7
MNT	2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE-5'-DIPHOSPHATE	A	1LVK	0.75
CF2	2'-deoxy-5'-O-{[2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl]carbamoyl}guanosine	A	2VKF	0.7
ONM	3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE-5'-TRIPHOSPHATE	A,C	1TL7	0.84
ONM	3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE-5'-TRIPHOSPHATE	A,C	1U0H	0.84
PD8	PHOSPHORYLATED DIHYDROPTEROATE	A	1W78	0.7
GSS		A	1AP1	0.78
5HI	(3R,5R)-7-[2-(4-fluorophenyl)-4-{[(1S)-2-hydroxy-1-phenylethyl]carbamoyl}-5-(1-methylethyl)-1H-imidazol-1-yl]-3,5-dihydroxyheptanoic acid	A,B,C,D	3CCZ	0.72
ONA		A,C	2GVZ	0.76
PUY	PUROMYCIN	A,B	2DPT	0.72
PUY	PUROMYCIN	1,2,4,5,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1Q7Y	0.72
N2G		A,P,T	2W8K	0.73
N2G		A,P,T	2W8L	0.73
4HI	(3R,5R)-7-[4-(benzylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-1H-imidazol-1-yl]-3,5-dihydroxyheptanoic acid	B,C,D	3CCW	0.72
BPG	9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE	A,B	1QHI	0.72
DBG	3-AMINOBENZOPHENONE-4-YL-AMINOHYDROXYPHOSPHINYLAMINOPHOSPHONIC ACID-GUANYLATE ESTER	A	1RVD	0.74
DBG	3-AMINOBENZOPHENONE-4-YL-AMINOHYDROXYPHOSPHINYLAMINOPHOSPHONIC ACID-GUANYLATE ESTER	A	1CLU	0.74
DOT	3'ANTHRANILOYL-2'-DEOXY-ADENOSINE-5'-TRIPHOSPHATE	A,B,C,D,E,F	1LVC	0.75
FR2	1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDW	0.74
MGQ	7-BENZYL GUANINE MONOPHOSPHATE	A,E	2V8X	0.78
MGV	P-FLUORO-7-BENZYL GUANINE MONOPHOSPHATE	A,E	2V8Y	0.76
FA5	ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE]	A	3CMQ	0.7
FA5	ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE]	A,B	1JJC	0.7
MS1		A,B	1OZ0	0.7
RUN	2-[(1R,3S,4S)-1-BENZYL-4-[N-(BENZYLOXYCARBONYL)-L-VALYL]AMINO-3-PHENYLPENTYL]-4(5)-(2-METHYLPROPIONYL)IMIDAZOLE	B	1HPS	0.72
FRC	1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE	A	1V7A	0.73
FR3	1-((1R)-1-(HYDROXYMETHYL)-3-(1-NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDY	0.71
FR6	1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}-1H-IMIDAZOLE-4-CARBOXAMIDE	A	2E1W	0.71
I2C	5'-O-[(S)-hydroxy{[2-hydroxy-3,5-dimethyl-6-(2-oxoethyl)pyridin-4-yl]oxy}phosphoryl]guanosine	A	3F47	0.71
I2C	5'-O-[(S)-hydroxy{[2-hydroxy-3,5-dimethyl-6-(2-oxoethyl)pyridin-4-yl]oxy}phosphoryl]guanosine	A	3F46	0.71
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	2ALY	0.7
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	1VBM	0.7
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	1VBN	0.7
YSA	5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE	A,B	2PID	0.7
GRD	benzyl (S)-1-((2S,3S)-1-(3-(6-amino-9H-purin-9-yl)propylamino)-2-hydroxy-1-oxopentan-3-ylamino)-4-methyl-1-oxopentan-2-ylcarbamate	A	2R9C	0.76
GSR		A	1AF1	0.78
NGD		A,B	2O3U	0.72
9DI	9-DEAZAINOSINE	A	1A9P	0.7
00A	5'-O-[(S)-{[(4-chlorophenyl)carbonyl]oxy}(hydroxy)phosphoryl]adenosine	X	3CW8	0.74
CAG		A	1GNQ	0.75
CAG		A	1PLJ	0.75
CAG		X	2EVW	0.75
CAG		A	1GNR	0.75
CAG		X	2CL6	0.75
AGN		A	1GNP	0.82
FEG	5'-O-[(S)-{[2-(carboxymethyl)-6-hydroxy-3,5-dimethylpyridin-4-yl]oxy}(hydroxy)phosphoryl]guanosine	A	3DAG	0.72
FEG	5'-O-[(S)-{[2-(carboxymethyl)-6-hydroxy-3,5-dimethylpyridin-4-yl]oxy}(hydroxy)phosphoryl]guanosine	A	3DAF	0.72